![Morgan Conn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Morgan Conn
Plus aucun poste en cours
Fortune : 163 278 $ au 31/08/2026
Profil
Morgan Conn formerly worked at PTC Therapeutics, Inc., as Vice President-Business Development from 2001 to 2017, Amherst College, as Assistant Professor, Century Therapeutics, Inc., as Chief Financial Officer from 2024 to 2025, and Pharvaris NV, as Chief Business Officer from 2017 to 2024.
Dr. Conn received his doctorate degree from Massachusetts Institute of Technology and undergraduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/03/2025 | 79 648 ( 0,04 % ) | 163 278 $ | 31/08/2026 |
Anciens postes connus de Morgan Conn
| Sociétés | Poste | Fin |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Directeur Financier/CFO | 11/07/2025 |
| PHARVARIS N.V. | Corporate Officer/Principal | 04/10/2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Morgan Conn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
 Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
